MyCAN Technologies Inc. (Head office: Kyoto, Japan; Representative Director: Kazuo Miyazaki) has raised approximately 250 million yen in total through the issuance of new shares from Osaka Small and Medium Business Investment & Consultation Co., Ltd. (Kita-ku, Osaka City; CEO: Kobayashi Toshinori), Kyoto City Startup Support Investment Limited Partnership No. 2 (General Partner: Future Venture Capital Co., Ltd., Minami-ku, Kyoto City; CEO: Sawada Daisuke), Chushin Venture & Investment Fund No. 7 Investment Limited Partnership (General Partner: Chushin Venture Capital Co., Ltd., Shimogyo-ku, Kyoto City; CEO: Imazu Takateru), Mitani Sangyo Co., Ltd. (Kanazawa City, Ishikawa Prefecture; CEO: Mitani Tadateru), and Minato Growth Enterprise Future Fund No. 2 Investment Limited Partnership (General Partner: Minato Capital Co., Ltd., Kobe City, Hyogo Prefecture; CEO: Yamazaki Koji).
We will use this funding to accelerate the development of a viral infection test using Mylc cells, which we are positioning as the next product after MylcMAT.
